Resistance to HER2-Targeted Therapy in HER2+ Breast Cancer.Published in:Clinical Medicine Reviews in Women's Health, 2012, n. 4, p. 15, doi. 10.4137/CMRWH.S3272By:Kessler, Elizabeth R.;Elias, Anthony D.Publication type:Article
Current and Emerging Pharmacotherapies for the Management of Hypertension, Focus on Aliskiren.Published in:Clinical Medicine Reviews in Women's Health, 2012, n. 4, p. 1, doi. 10.4137/CMRWH.S5963By:Derosa, Giuseppe;Maffioli, PamelaPublication type:Article